BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:48 PM
 | 
Mar 31, 2010
 |  BC Extra  |  Politics & Policy

Cohen to lead BIO's Emerging Companies Section

Ron Cohen, president and CEO of Acorda Therapeutics Inc. (NASDAQ:ACOR), is expected to be elected chairman of the Biotechnology Industry Organization's Emerging Companies...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >